Clinical, geographical, and temporal risk factors associated with presentation and outcome of vivax malaria imported into the United Kingdom over 27 years: Observational study

BMJ (Online)

Volumn 350, Issue , 2015, Pages

  Broderick, Claire ^a   Nadjm, Behzad ^b   Smith, Valerie ^a   Blaze, Marie ^a   Checkley, Anna ^b   Chiodini, Peter L ^a   Whitty, Christopher J M ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b HOSPITAL FOR TROPICAL DISEASES   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CLINICAL FEATURE; CONFIDENCE INTERVAL; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE SURVEILLANCE; GEOGRAPHY; HUMAN; INDIA; INFECTION CONTROL; INFECTION RISK; LATENT PERIOD; MAJOR CLINICAL STUDY; MIDDLE AGED; MORTALITY; OBSERVATIONAL STUDY; PAKISTAN; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; SEASONAL VARIATION; SOUTH ASIA; SUMMER; TRAVEL; UNITED KINGDOM; YOUNG ADULT; FEMALE; MALARIA, VIVAX; MALE; SOCIOECONOMICS; TIME;

ADULT; AGED; FEMALE; GREAT BRITAIN; HUMANS; MALARIA, VIVAX; MALE; MIDDLE AGED; RISK FACTORS; SOCIOECONOMIC FACTORS; TIME FACTORS; TRAVEL; YOUNG ADULT;

EID: 84929485781     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.h1703     Document Type: Article

References (44)

1. Price RN, Tjitra E, Guerra CA, et al. Vivax malaria: neglected and not benign. Am J Trop Med Hyg 2007;77(6 Suppl):79-87.
2. Mueller I, Galinski MR, Baird JK, et al. Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite. Lancet Infect Dis 2009;9:555-66.
3. Baird JK. Neglect of Plasmodium vivax malaria. Trends Parasitol 2007;23:533-9.
4. Quispe AM, Pozo E, Guerrero E, et al. Plasmodium vivax hospitalizations in a monoendemic malaria region: severe vivax malaria? Am J Trop Med Hyg 2014;91:11-7.
5. Kochar DK, Saxena V, Singh N, et al. Plasmodium vivax malaria. Emerg Infect Dis 2005;11:132-4.
6. Barcus MJ, Basri H, Picarima H, et al. Demographic risk factors for severe and fatal vivax and falciparum malaria among hospital admissions in northeastern Indonesian Papua. Am J Trop Med Hyg 2007;77:984-91.
7. Smith AD, Bradley DJ, Smith V, et al. Imported malaria and high risk groups: observational study using UK surveillance data 1987-2006. BMJ 2008;337:a120.
8. Krotoski W. A. Discovery of the hypnozoite and a new theory of malarial relapse. Trans R Soc Trop Med Hyg 1985;79:1-11.
9. Battle KE, Karhunen MS, Bhatt S, et al. Geographical variation in Plasmodium vivax relapse. Malar J 2014;13:144.
10. Lover AA, Coker RJ. Quantifying effect of geographic location on epidemiology of Plasmodium vivax malaria. Emerg Infect Dis 2013;19:1058-65.
11. White NJ. Determinants of relapse periodicity in Plasmodium vivax malaria. Malar J 2011;10:297.
12. Bottieau E, Clerinx J, Van Den Enden E, et al. Imported non-Plasmodium falciparum malaria: a five-year prospective study in a European referral center. Am J Trop Med Hyg 2006;75:133-8.
13. Willocks L, Jones M, Brettle R, et al. Changing patterns of malaria in south-east Scotland: implications for practitioner awareness and prophylactic advice. Postgrad Med J 1992;68:22-5.
14. Cathcart SJ, Lawrence J, Grant A, et al. Estimating unreported malaria cases in England: a capture-recapture study. Epidemiol Infect 2010;138:1052-8.
15. Office for National Statistics. 2014. www.ons.gov. uk/ons/guide-method/method-quality/specific/travel-and-transportmethodology/international-passenger-survey/index.html.
16. Office for National Statistics. 2014. www.ons.gov. uk/ons/guide-method/geography/beginner-s-guide/administrative/england/government-ofice-regions/index.html.
17. Chiodini PL, Field V K, Whitty CJM, et al. Guidelines for malaria prevention in travellers from the United Kingdom 2014. Public Health England, 2014.
18. Schlagenhauf P, Steffen R, Loutan L. Migrants as a major risk group for imported malaria in European countries. J Travel Med 2003;10:106-7.
19. Angell SY, Cetron MS. Health disparities among travellers visiting friends and relatives abroad. Ann Intern Med 2005;142:67-72.
20. Angell SY, Behrens RH. Risk assessment and disease prevention in travellers visiting friends and relatives. Infect Dis Clin North Am 2005;19:49-65.
21. Scolari C, Tedoldi S, Casalini C, et al. Knowledge, attitudes, and practices on malaria preventive measures of migrants attending a public health clinic in northern Italy. J Travel Med 2002;9:160-2.
22. Dos Santos CC, Anvar A, Keystone JS, et al. Survey of use of malaria prevention measures by Canadians visiting India. CMAJ 1999;160:195-200.
23. Checkley AM, Smith A, Smith V, et al. Risk factors for mortality from imported falciparum malaria in the United Kingdom over 20 years: an observational study. BMJ 2012;344:e2116.
24. Greenberg AE, Lobel HO. Mortality from Plasmodium falciparum malaria in travelers from the United States, 1959 to 1987. Ann Intern Med 1990;113:326-7.
25. Muhlberger N, Jelinek T, Behrens RH, et al. Age as a risk factor for severe manifestations and fatal outcome of falciparum malaria in European patients: observations from TropNetEurop and SIMPID Surveillance Data. Clin Infect Dis 2003;36:990-5.
26. Gjorup IE, Ronn A. Malaria in elderly non-immune travellers. J Travel Med 2002;9:91-3.
27. Mühlberger N, Jelinek T, Gascon J, et al. Epidemiology and clinical features of vivax malaria imported to Europe: sentinel surveillance data from TropNetEurop. Malar J 2004;3:5.
28. Health Protection Agency. Migrant Health. Infectious diseases in non-UK born populations in England, Wales and Northern Ireland. A baseline report-2006. November 2006.
29. Nolder D, Oguike MC, Maxwell-Scott H, et al. An observational study of malaria in British travellers: Plasmodium ovale wallikeri and Plasmodium ovale curtisi differ significantly in the duration of latency. BMJ Open 2013;3. pii:e002711.
30. Venkatesan P, Dedicoat M, Innes JA, et al. Seasonality of presentation of imported Plasmodium vivax malaria in Birmingham, UK. Trans R Soc Trop Med Hyg 2003;97:550.
31. Warwick R, Swimmer GJ, Britt RP. Prolonged incubation period of imported P.vivax malaria in London. J R Soc Med 1980;73:333-6.
32. Walker E. The seasonal pattern of Plasmodium vivax malaria in Glasgow. J Infect 1983;7:227-30.
33. Garnham PCC. Malaria parasites of man: life-cycles and morphology. In: Wernsdorfer WH, McGregor IA, eds. Malaria: principles and practice of malariology. Churchill Livingstone; 1988:69.
34. White NJ. Determinants of relapse periodicity in Plasmodium vivax malaria. Malar J 2011;10:297.
35. Battle KE, Karhunen MS, Bhatt S, et al. Geographical variation in Plasmodium vivax relapse. Malar J 2014;13:144.
36. Shanks GD, White NJ. The activation of vivax malaria hypnozoites by infectious diseases. Lancet Infect Dis 2013;13:900-6.
37. Dembélé L, Franetich JF, Lorthiois A, et al. Persistence and activation of malaria hypnozoites in long-term primary hepatocyte cultures. Nat Med 2014;20:307-12.
38. Barnwell JW, Galinski MR. Malarial liver parasites awaken in culture. Nat Med 2014;20:237-9.
39. Cairns M, Roca-Feltrer A, Garske T, et al. Estimating the potential public health impact of seasonal malaria chemoprevention in African children. Nat Commun 2012;3:881.
40. World Health Organization. World malaria report: 2013. WHO, 2013.
41. Stark K, Schöneberg I. Increase in malaria cases imported from Pakistan to Germany in 2012. Euro Surveill 2012;17(47): pii=20320.
42. Odolini S, Gautret P, Kain KC, et al. Imported Plasmodium vivax Malaria ex Pakistan. J Travel Med 2014;21:314-7.
43. Schwartz E, Parise M, Kozarsky P, et al. Delayed onset of malaria-implications for chemoprophylaxis in travelers. N Engl J Med 2003;349:1510-6.
44. Government of India. Tourism statistics 2013 (New Delhi 2013) http://tourism.gov.in/writereaddata/CMSPagePicture/file/marketresearch/publications/IndiaTourismStatics2013-1.pdf.